RCM
PFE icon

Riverloft Capital Management’s Pfizer PFE Stock Holding History

Riverloft Capital Management’s Portfolio PFE Stock Details PFE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q4 		– Sell
-52,700
Closed -$1.57M – 48
2015
Q3 		$1.57M Buy
+52,700
New +$1.69M 0.6% 25

Other funds holding PFE

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Riverloft Capital Management's PFE Position: Q4 2015 in Review

Riverloft Capital Management sold out of Pfizer (PFE) in Q4 2015, closing a stake of 52,700 shares — an estimated $1.57M sold.

Riverloft Capital Management first reported a position in PFE in Q3 2015 and held it in 1 quarter. The position peaked at $1.57M in Q3 2015. 1,970 funds tracked by Wall St. Rank hold PFE as of Q4 2015.

  • Riverloft Capital Management reported no remaining Pfizer position as of Q4 2015 after selling out during the quarter.
  • Riverloft Capital Management sold 52,700 Pfizer shares in Q4 2015, an estimated $1.57M.
  • Riverloft Capital Management first reported a position in Pfizer in Q3 2015 and held it in 1 quarter.
  • Riverloft Capital Management's Pfizer position peaked at $1.57M in Q3 2015.
  • 1,970 funds tracked by Wall St. Rank held Pfizer as of Q4 2015.

Based on Riverloft Capital Management's 13F filing for Q4 2015, filed 16 Feb 2016.